Stay updated on Nivolumab vs Temozolomide in GBM Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.

Latest updates to the Nivolumab vs Temozolomide in GBM Clinical Trial page
- Check7 days agoChange DetectedThe page’s revision tag was updated from v3.5.4 to v3.5.5, indicating a minor metadata update rather than a change to the study information.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.5.4 has been added and the previous Revision: v3.5.3 has been removed on the page. This reflects an internal update to the page’s versioning label rather than a change to user-facing content or functionality.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page’s site footer version has been updated from **v3.5.2** to **v3.5.3**, indicating a minor platform/content delivery revision rather than any change to the study record.SummaryDifference0.0%

- Check58 days agoChange DetectedThe collaborator entry was updated to Ono Pharmaceutical Co., Ltd. (replacing Ono Pharmaceutical Co. Ltd). The document revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check72 days agoChange DetectedAdded Padova, Italy, 35128 and removed Padua, Italy, 35128 from the locations list.SummaryDifference0.0%

- Check87 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Temozolomide in GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.